Safety and efficacy of the Mynx Control vascular closure device in peripheral arterial procedures: A prospective study.
Vascular
; 31(2): 369-374, 2023 Apr.
Article
en En
| MEDLINE
| ID: mdl-34958621
ABSTRACT
OBJECTIVES:
This article aims to present a prospective study investigating the safety and efficacy of the Mynx Control extravascular closure device (Cordis Corporation, FL, USA), for femoral arterial closure in patients undergoing peripheral arterial procedures.METHODS:
Between January 2020 and February 2021, 100 Mynx Control devices were deployed in 91 consecutive patients (mean age 67.5 ± 16.9 years) who underwent peripheral arterial procedures. We used ultrasound and/or fluoroscopy during Mynx Control deployment and ultrasound post-procedure to detect complications. Femoral artery punctures included 62 (62%) antegrade and 38 (38%) retrograde punctures. The mean activated clotting time at time of device deployment was 221s. The primary endpoints were technical success, device failure, and complication rates up to 30 days.RESULTS:
A 5F vascular sheath was used in 43 cases (43%) (36 (36%) 6F and 21 (21%) 7F). The majority of our cases had antegrade access (62%). Overall technical success rate was 97% in both antegrade and retrograde cases. In total, there were 4 minor complications 3 (3%) cases of pseudoaneurysm and 1 (1%) case of haematoma. No major complications were recorded post-procedure or 30 days post index procedure.CONCLUSION:
The Mynx Control vascular closure device is safe and effective in achieving haemostasis in patients undergoing antegrade and retrograde peripheral angioplasty procedures.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Dispositivos de Cierre Vascular
Tipo de estudio:
Observational_studies
Límite:
Aged
/
Aged80
/
Humans
/
Middle aged
Idioma:
En
Revista:
Vascular
Asunto de la revista:
ANGIOLOGIA
/
CARDIOLOGIA
Año:
2023
Tipo del documento:
Article
País de afiliación:
Reino Unido